11 Patents
- US126007322026Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
NURIX THERAPEUTICS, Inc.
0 cites - 0 cites
- US125827222026Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
NURIX THERAPEUTICS, Inc.
0 cites - US125838622026Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
NURIX THERAPEUTICS, Inc.
0 cites - US1248514420253-substituted Piperidine Compounds for Cbl-b Inhibition, and Use Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US123771062025Piperidinylpyrazine-carboxamide Compounds for Treating and Preventing Cancer and for Degrading BTK
NURIX THERAPEUTICS, Inc.
0 cites - US122342302025Substituted Benzyl-triazole Compounds for Cbl-b Inhibition, and Further Uses Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US120494712024Cyano Cyclobutyl Compounds for Cbl-b Inhibition and Uses Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US1195113320243-substituted Piperidine Compounds for Cbl-b Inhibition, and Use Thereof
NURIX THERAPEUTICS, Inc.
0 cites - US118664422024Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
NURIX THERAPEUTICS, Inc.
0 cites - US118207812023Bifunctional Compounds for Degrading BTK via Ubiquitin Proteosome Pathway
Nurix Therapeutics, Inc.
0 cites